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Abstract 
Objectives: Evaluation of the extent and appropriateness of antimicrobial use is a cornerstone of antibiotic stew-
ardship programs, but it is time-consuming. Documentation of the indication at the moment of prescription might 
be more time-efficient. We investigated the real-life feasibility of mandatory documentation of the indication for all 
hospital antibiotic prescriptions for quality evaluation purposes.
Methods: A mandatory prescription-indication format was implemented in the Electronic Medical Record (EMR) of 
three hospitals using EPIC or ChipSoft HIX software. We evaluated the retrieved data of all antibiotics (J01) prescribed 
as empiric therapy in adult patients with respiratory tract infections (RTI) or urinary tract infections (UTI), from January 
through December 2017 in Hospital A, June through October 2019 in Hospital B and May 2019 through June 2020 
in Hospital C. Endpoints were the accuracy of the data, defined as agreement between selected indication for the 
prescription and the documented indication in the EMR, as assessed by manually screening a representative sample 
of eligible patient records in the EMR of the three hospitals, and appropriateness of the prescriptions, defined as the 
prescriptions being in accordance with the national guidelines.
Results: The datasets of hospitals A, B and C contained 9588, 338 and 5816 empiric antibiotic prescriptions indicated 
for RTI or UTI, respectively. The selected indication was in accordance with the documented indication in 96.7% (error 
rate: 10/300), 78.2% (error rate: 53/243), and 86.9% (error rate: 39/298), respectively. A considerable variation in guide-
line adherence was seen between the hospitals for severe community acquired pneumonia (adherence rate ranged 
from 35.4 to 53.0%), complicated UTI (40.0–67.1%) and cystitis (5.6–45.3%).
Conclusions: After local validation of the datasets to verify and optimize accuracy of the data, mandatory documen-
tation of the indication for antibiotics enables a reliable and time-efficient method for systematic registration of the 
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Background
Antibiotic Stewardship Programmes (ASPs) have been 
developed to measure and improve the appropriateness 
of antibiotic use while minimizing unintended conse-
quences of antibiotic use [1–3]. To measure appropriate-
ness, quality indicators (QIs) have been established and 
validated [4]. One of the QIs is prescribing antimicrobials 
in accordance with the local guideline, or, if not available, 
national or international guidelines. Guideline-adher-
ent empiric therapy has shown to be associated with 
improved clinical outcome [1, 5] .
A frequently used method to evaluate the appropri-
ateness of antimicrobial use in a hospital is the point 
prevalence survey (PPS), in which all antimicrobial pre-
scriptions and their indications are retrieved during 
a certain time period [6, 7]. This is done by manually 
reviewing the (electronic) medical record (EMR). In many 
cases contact with the attending physician is necessary 
because of incomplete records, and therefore the evalu-
ation of appropriateness can be very time-consuming. 
This often results in the evaluation of a relatively small 
number of patients and a low frequency of analysis, lim-
ited to hospitals with available personnel and resources 
[8]. This calls for a more efficient method to evaluate the 
appropriateness of antimicrobial use, in order to perform 
measurements more often or on a larger scale.
EMR tools have already been shown to facilitate ASPs, 
by computerised decision support, and surveillance of 
the use of restricted antimicrobials and potential IV-
to-oral switch candidates [9–12]. In previous studies 
it was also shown that in a study setting EMR tools are 
able to link antibiotic orders to indications, which could 
facilitate standardized data collection and an automated 
assessment of antibiotic appropriateness as well [12–18].
The aim of this study was to investigate the real-life fea-
sibility of mandatory documentation of the indication for 
all antibiotic prescriptions, for the purpose of systematic 
evaluation of not only the extent, but also the appropri-
ateness of antimicrobial use. This might also facilitate 
national antimicrobial use surveillance and benchmark-
ing on the hospital level. We implemented a standard-
ized prescription-format in the EMR of three hospitals, 
two hospitals using EPIC and the other using ChipSoft 
HIX EMR software, and subsequently extracted the data. 
This is a feasibility study, as we describe the technical 
aspects of incorporating these order menus into the EMR 
and validated the extracted data against the source data 
in the EMR [19, 20]. In addition, we assessed whether the 
extracted data can be used to evaluate the compliance 
rate to national guidelines. For the purpose of this study, 
we focused on antibiotics prescribed as empiric therapy 
for patients with respiratory tract infections (RTI) or uri-
nary tract infections (UTI), since these are the most com-
mon infections in hospitals.
Methods
Study design and setting
The study was performed in three hospitals in the Neth-
erlands. The participating hospitals were the OLVG Hos-
pital (Hospital A), Amsterdam, a 663-bed non-academic 
teaching hospital, treating more than 500,000 patients 
annually; the Antonius Hospital (Hospital B), Sneek, a 
300-bed non-academic hospital, treating 200,000 patients 
annually; and the Radboud University Medical Center 
(Hospital C), Nijmegen, a 593-bed academic teaching 
hospital, treating over 300,000 patients annually. At all 
hospitals an ASP is present, including an Antibiotic stew-
ardship team (AST), consisting of an infectious diseases 
specialist, hospital pharmacist and medical microbiolo-
gist. The study consisted of two phases: (1) assessment of 
feasibility in hospitals using different EMR and prescrib-
ing software: Hospital A using EPIC software, and Hospi-
tal B using Chipsoft HIX software (August 2018–January 
2020); (2) confirmation of feasibility in another hospital 
using the same EMR and prescribing software: Hospital 
C using EPIC software (May 2020–September 2020).
Approval from the Institutional review boards was not 
required for this study because we used retrospective, 
pseudonymized data for quality optimization purposes. 
Procedures were in accordance with the General Data 
Protection Regulation [21].
Data collection and procedures
A standardized prescription-format was implemented in 
the EMR and prescribing software of the participating 
hospitals by software-specific IT specialists. The format 
obliges physicians to select the indication for the pre-
scription from a predefined list whenever they prescribe 
an antimicrobial agent to be administered systemically. 
The possible indications are empiric therapy, targeted 
therapy or prophylaxis. Subsequently they have to select 
extent and appropriateness of empiric antimicrobial use, which might enable benchmarking both in-hospital and 
between hospitals.
Keywords: Antibiotic prescribing, Antibiotic indication, Antibiotic stewardship, National surveillance, Benchmarking, 
Quality of care
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the main focus of infection, first on tract level, followed 
by a further specification (Additional file 1: Fig. S1–S3).
Hospital A already implemented the mandatory indi-
cation registration in 2015. This prescription format 
was used as the basis for our feasibility study. Hospital A 
retrieved data covering the period January 1, 2017, until 
December 31, 2017. After visual inspection of the data, 
amendments were made for a more detailed indication 
registration, which was implemented in the prescription-
format of Hospital B in 2018 and Hospital C in 2019. 
Hospital B provided data covering the period June 1, 
2019 until October 31, 2019 and Hospital C covering the 
period May 14, 2019 until June 9, 2020.
The hospitals extracted datasets from the EMR con-
taining the following parameters:
• Coded patient identifier and admission identifier
• All antibiotic prescriptions for systemic use belong-
ing to Anatomical Therapeutic Chemical (ATC) class 
J01
• The duration of therapy (start and stop date), dose 
regimen and route of administration
• The specialty/department of the authorizing and 
ordering prescriber, and ward of admission of the 
patient
• Time and date of admission and discharge, i.e. dura-
tion of admission
• The chosen focus of infection on tract level, specified 
in case of RTI or UTI
Further procedures were performed by the authors of 
the study. For the purpose of this study, we selected the 
antibiotic prescriptions of all hospitalized patients aged 
18  years and older, admitted to any general ward, and 
receiving empiric antibiotic treatment for an RTI or UTI. 
Hospitalized clinical patients were defined as patients 
admitted to the ward for at least 12  h. Empiric therapy 
was defined as the prescribed antibiotic (combination) 
therapy at time point 24 h of hospitalization, or the last 
prescribed antibiotic therapy at the time of discharge in 
patients who were hospitalized for 12–24  h. This defi-
nition of empiric therapy was chosen because febrile 
patients often receive empiric antibiotic treatment as 
soon as possible after presentation. During the first hours 
of admission, incoming diagnostic results may lead to 
adjustment of the initial indication and therapy. There-
fore, we reasoned that the prescriptions that were pre-
scribed at time point 24 h of hospitalization would most 
accurately reflect the empiric therapy for the indications 
of interest. After 24 h, empiric therapy is usually adjusted 
to targeted therapy. We considered antibiotics that were 
prescribed simultaneously for the same specified indi-
cation as antibiotic combination therapy. We excluded 
ICU patients, because the ICU of Hospital A and B 
use another EMR; readmissions (defined as an admis-
sion within 30  days after the initial hospital discharge), 
because guideline-recommended empiric treatment is 
usually not applicable; prescriptions of patients with both 
RTI and UTI; and erroneous prescriptions, these were 
prescriptions of which the start date of the antibiotic fell 
before the date of admission. Furthermore, we excluded 
the prescriptions for RTI in hospital C that were pre-
scribed after March 2020, because initially no guideline 
was available for COVID-19 RTI. Exclusion criteria were 
applied electronically.
The primary endpoint of the study was the accuracy of 
the dataset, defined as percentage agreement between 
the selected indication for the prescription and the docu-
mented indication in the EMR. The secondary endpoint 
was the percentage of antibiotic prescriptions in each 
hospital that was prescribed according to the national 
guidelines.
Validation of the dataset
We determined what data had to be extracted from the 
EMR to be able to select the prescriptions that met the 
inclusion criteria, and we evaluated the correctness of the 
datasets. This was first done through general inspection 
and if deemed necessary through manual chart review of 
records. Counterintuitive results were resolved. Next, we 
verified the accuracy of the datasets by manually screen-
ing a representative sample of eligible patient records in 
the EMR of the three hospitals on:
1. whether the indications RTI or UTI and their sub-
sequent specifications selected as indication for the 
antibiotic prescription were in accordance with the 
documented diagnosis in the patient record. For this, 
we screened 200 electronically, randomly selected 
patient records in Hospital A and C and the 143 
patient records with these indications in Hospital B.
2. whether selected indications other than RTI/UTI 
were in accordance with the documented diagno-
sis and RTI/UTI infections were thus not accidently 
excluded. For this we screened 100 electronically, 
randomly selected records in all hospitals.
Appropriateness of prescriptions
After validating the dataset, we measured the appropri-
ateness of the prescriptions. This was done by evaluat-
ing whether the prescribed antibiotics for the selected 
indications were in accordance with the national guide-
lines of the Dutch Working party on Antibiotic Policy 
(www. swabid. nl), which contain treatment recommen-
dations for all common infections. In the Netherlands, 
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the national guidelines often provide several possible 
empiric treatment recommendations, from which the 
local hospital guidelines can select a number of options 
[22]. By using the national guidelines as a reference, it is 
possible to benchmark inpatient antibiotic use between 
hospitals. The prescribed antibiotics were categorised as 
(A) in accordance with the guideline-recommended first 
choice agents; (B) in accordance with the guideline-rec-
ommended second choice agents; (C) discordant with the 
guideline. The appropriateness of the prescriptions linked 
to the RTI/UTI sub-indication “other” was not measured.
Data analysis
Descriptive data are presented in numbers with or with-
out percentages, for which SAS version 9.4 (SAS Institute 
Inc., USA) was used. We did not aim to statistically com-
pare the appropriateness of prescriptions between the 
three hospitals, as the purpose of the study was to show 
the feasibility of quality measurements with the use of 
the mandatory prescription-indication tool with subse-
quent data extraction from the EMR.
Results
Dataset characteristics and validation
The datasets of the three hospitals contained 31,769 
(Hospital A), 2841 (Hospital B) and 25,058 (Hospital 
C) systemic antibiotic (J01) prescriptions, respectively 
(Fig. 1). Of these, 9588 (30%), 338 (12%) and 5816 (23%), 
respectively, had the indication RTI or UTI or both.
Number of anbioc prescripons (J01)
Hospital A: n=31769 Hospital B: n=2841 Hospital C: n=25058
Records excluded:
- therapy >24 h aer admission (A: 6706, B: 
181, C: 4392)
- prescripon linked to both RTI and UTI (A: 
96, B:-, C: 20)
- ICU prescripons (A:-, B:-, C: 65) 
Records excluded:
- erroneous prescripons (A: 14, B: -, C:-)
- readmissions (A: 256, B: 15, C: 223)
- paediatrics (A: 238, B:-, C: 67)
- prophylaxis (A: 95, B: -, C:-)
- prescripons stopped unl further noce (A: 
7, B:-, C:-)
Empiric anbioc prescripons for hospitalized adult paents 
with RTI or UTI
Hospital A: n=2176 Hospital B: n=142 Hospital C: n=1049
RTI: n= 1492 RTI: n =74 RTI: n=505
UTI: n= 684 UTI: n=68 UTI: n=544
Empiric anbioc (combinaon) therapy for hospitalized adult 
paents with RTI or UTI
Hospital A: n=1910 Hospital B: n=130 Hospital C: n=981
RTI: n=1248 RTI: n=66 RTI: n=461
UTI: n=662 UTI: n=64 UTI: n=520
Anbioc prescripons for RTI and UTI
Hospital A: n=9588* Hospital B: n=338 Hospital C: n=5816*
RTI: n=6082 RTI: n=135 RTI: n=3008
UTI: n=3602 UTI: n=203 UTI: n=2881
Empiric anbioc prescripons for RTI or UTI
Hospital A: n=2786 Hospital B: n=157 Hospital C: n=1339
RTI: n=1882 RTI: n=77 RTI: n=634
UTI: n=904 UTI: n=80 UTI: n=705
Fig. 1 Antibiotic prescriptions in Hospital A, B and C. A, Hospital A; B, Hospital B; C, Hospital C.*The number presents the total amount of 
prescribed antibiotics for RTI and UTI. Some prescriptions were linked to both theindications RTI and UTI. Therefore, the total amount of prescribed 
antibiotics is lower than the sum of prescriptions indicatedfor RTI and UTI
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The datasets were first checked on correctness by gen-
eral inspection. Counterintuitive results were further 
investigated and resolved. For example, the number of 
antibiotic prescriptions in Hospital B was initially very 
low, which turned out to be caused by the setting of the 
EMR tool that enabled optional indication registration 
instead of mandatory registration. For the final dataset 
we therefore used the data that was extracted after this 
problem was solved (from June 2019 onwards).
Next, for the data elements provided in addition to the 
antibiotic prescriptions and indications, we investigated 
what data needed to be extracted to get the most accu-
rate presentation of our predefined selections. For exam-
ple, to get the most accurate presentation of the patient’s 
department of admission, for Hospital A the variable 
“specialty of authorizing prescriber” had to be extracted, 
and “specialty of admission” for Hospital B.
Furthermore, we evaluated 87 (n = 30 + 27 + 30 for 
Hospital A, B and C, respectively) patients in whom 
hospital-acquired pneumonia (HAP) or prophylaxis was 
selected. HAP was evaluated to determine what defini-
tion for HAP was used by the prescribers in the three 
hospitals. In all hospitals HAP was (correctly) defined as 
pneumonia acquired after recent hospital or healthcare 
centre admission, for instance nursing homes. Prophy-
laxis was evaluated because the EMR tool in Hospital A 
required registering the focus of infection when selecting 
the indication prophylaxis, indicating that the antibiotic 
might be prescribed as therapy instead of prophylaxis. 
Evaluation of a sample of the prophylactic prescriptions 
confirmed that 48 out of 53 (n = 15 + 23 + 15 for Hos-
pital A, B and C, respectively) prescriptions were truly 
prescribed as prophylaxis and not as therapy, and these 
prescriptions were therefore justly excluded.
To verify the accuracy of the data, we compared the 
selected indication with the diagnosis as recorded in the 
EMR for 300 patients (Hospital A and C) and 243 patients 
(Hospital B) (Table 1). Overall, the selected indication did 
not match with the documented diagnosis in 3.3% of the 
300 cases in Hospital A, 21.8% of 243 cases in Hospital B 
and 13.1% of 298 cases in Hospital C. Indication selection 
errors were mostly due to inaccurate sub-indications. The 
error rate of Hospital B and C was explained mainly by 
incorrect selection of cystitis when a complicated UTI 
(urosepsis or pyelonephritis) was documented in the case 
notes (n = 37 for Hospital B, and n = 20 for Hospital C). 
Table 1 Verification of selected indications
CAP-m community-acquired pneumonia—mild to moderate severe, CAP-s community-acquired pneumonia—severe
a 1 record could not be validated, because documentation regarding the indication of antibiotic treatment was missing/not accessible
b Random samples, other than RTI/UTI
Samples Hospital A (inaccurate 
selections/number of 
screened records)
Hospital B (inaccurate 
selections/number of screened 
records)
Hospital C (inaccurate 
selections/number of screened 
records)
RTI—error rate (%) 4/100 (4%) 7/70 (10%) 17/99a (17%)
Selected indication versus documented diagnosis 1 prophylaxis ↔ HAP 3 CAP-m ↔ COPD 4 CAP ↔ other
1 CAP ↔ COPD 1 CAP-s ↔ CAP-m 1 CAP-m ↔ COPD
1 CAP ↔ bronchitis 2 COPD ↔ CAP-m 1 Bronchitis ↔ COPD
1 other ↔ skin and soft 
tissue infections
1 aspiration pneumonia ↔ CAP-s 1 Bronchitis ↔ CAP
3 CAP ↔ aspiration pneumonia
3 HAP ↔ other
1 CAP-s ↔ CAP-m
2 CAP-m ↔ HAP
1 CAP-m ↔ prophylaxis
UTI—error rate (%) 6/100 (6%) 39/73 (53%) 20/99a (20%)
Selected indication versus documented diagnosis 5 cystitis ↔ complicated UTI 37 cystitis ↔ complicated UTI 20 cystitis ↔ complicated UTI
1 prophylaxis ↔ cystitis 1 chronic prostatitis ↔ urosepsis
1 other ↔ urosepsis
Randomb—error rate (%) 0/100 (0%) 7/100 (7%) 2/100 (2%)
4 missed UTI 1 missed UTI
3 missed RTI 1 missed RTI
Total error rate (%) 3.3% 21.8% 13.1%
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In Hospital C the option “other” was missing as possi-
ble RTI-specification, resulting in 7 incorrect selections, 
as prescribers seemed to select the second best option. 
Of the randomly selected records with indications other 
than RTI/UTI, 7 prescriptions indicated for RTI/UTI 
were missed in Hospital B, only 2 in Hospital C and none 
in Hospital A. This shows that, depending on the hospi-
tal, we have missed a number of prescriptions for RTI/
UTI.
Appropriateness of antibiotic prescriptions
After selecting the empirically prescribed antibiotics 
and excluding the records that fulfilled exclusion criteria 
(Fig. 1), 5% of the total amount of prescribed antibiotics 
remained: 2071 prescriptions for RTI (n = 1492, n = 74 
and n = 505, respectively) and 1296 prescriptions for UTI 
(n = 684, n = 68 and n = 544, respectively).
Prescriptions that were simultaneously prescribed 
for the same indication were considered combination 
therapy and were therefore merged for the final analysis 
of empirically prescribed antibiotic therapy per patient, 
after which 1775 antibiotic therapies remained for RTI 
(n = 1248, n = 66 and n = 461) and 1246 for UTI (n = 662, 
n = 64 and n = 520). The antibiotics prescribed for all RTI 
and UTI subindications in the three hospitals are pre-
sented in Additional file 1: Tables S1–S6.
The appropriateness of antibiotic therapy for RTI and 
UTI are presented in Figs.  2 and 3, respectively. The 
adherence rate to the national guidelines differed consid-
erably between the hospitals, which gives a clear illustra-
tion of the opportunities for benchmarking on hospital 
level.
Respiratory tract infections
For Hospital A, mild to moderate–severe and severe 
CAP were not distinguished in the EMR. For CAP, over-
all guideline adherence rate was 49.5%, mainly due to 
the frequent appropriate use of amoxicillin (25.5%) and 
ceftriaxone (18.8%). Hospital B and Hospital C did dis-
tinguish between mild to moderate–severe versus severe 
CAP, using the CURB-65 score. The adherence rate for 
mild to moderate–severe CAP was similar for Hospital B 
and Hospital C (33.4% and 38.5% respectively). The low 
guideline adherence rate was mainly due to the frequent 
inappropriate use of cefuroxime in Hospital B (35.4%) 
and ceftriaxone in Hospital C (17%). In all three hospi-
tals, amoxicillin–clavulanic acid (ACA) was inappropri-
ately prescribed in 15.5–18.8% of cases. The adherence 
rate for severe CAP was 35.4% for Hospital B and 53.0% 
for Hospital C. For severe CAP a wide variation of inap-
propriate therapy combinations was seen.
The guideline adherence rate for COPD exacerbations 
and HAP (in this study: pneumonia acquired in other 
health care institutions, for instance nursing homes) 









































































































Fig. 2 Appropriateness of antibiotics for RTI. Category A in accordance with the guideline-recommended first choice agents, marked in green; 
B in accordance with the guideline-recommended second choice agents, marked in yellow; C discordant with the guideline, marked in red; and 
other: antibiotics prescribed in less than 5% of cases, marked in grey
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adherence rates ranged from 40.0 to 52.5% for COPD and 
51.0–73.2% for HAP.
Urinary tract infections
The guideline adherence rate for complicated UTI was 
67.1% in Hospital A, 40.0% in Hospital B and 56.6% in 
Hospital C. In Hospital A and C, complicated UTI was 
mainly treated with ceftriaxone (51.1% and 51.3% respec-
tively). In Hospital B, complicated UTI was either treated 
with ceftriaxone, cefuroxime or ACA, of which the last 
two agents are considered inappropriate. Cefuroxime was 
the second most prescribed agent in Hospital C as well.
The antibiotic use for cystitis was appropriate in 45.3% 
in Hospital A, 5.6% in Hospital B and 28.1% in Hospi-
tal C. In all hospitals ACA, ceftriaxone or cefuroxime 
were commonly prescribed, which are all considered 
inappropriate.
Discussion
With this study we demonstrated that it is feasible to 
introduce mandatory documentation of the indication at 
the moment of antibiotic prescribing, using a prescrip-
tion format implemented in the EMR. In order to use 
the data extracted from the EMR for quality measure-
ments, an initial local validation and if indicated optimi-
zation of the datasets is necessary, which was shown in 
our results. The error rate of the prescription-indication 
tool ranged from 3.3 (Hospital A) to 21.8% (Hospital B)—
the latter because cystitis was often not correctly used 
as indication for the prescription. We also demonstrated 
that the retrieved data enable the evaluation of the appro-
priateness of the prescriptions for empiric therapy. For 
RTI and UTI a considerable variation in guideline adher-
ence was seen between the hospitals, giving an example 
of the opportunities of benchmarking on hospital level.
In previous studies, the prescription-indication tools 
were either implemented in hospital-specific software, 
or the indications were determined by and specific for 
the institution [16–18, 23, 24]. Therefore, the gener-
alizability of these tools has been subject of debate and 
quality measurements were restricted to single hospi-
tals [16–18, 23, 24]. In this feasibility study, we imple-
mented the prescription-indication tool in two nationally 
and internationally widely used EMR software packages 
(ChipSoft  HIX and EPIC). Also, we standardized the 
indications that the prescribers could choose from, which 
enabled benchmarking of the results on the national level. 
More variables can be extracted and data can be further 
stratified for a more detailed examination of antibiotic 
use, for example when evaluation of antibiotic use on 
department/local level is desired. Nevertheless, the out-
put of the extracted data of the EMR may vary between 
hospitals. For example, we noticed a difference in how 
the prescriber’s department was displayed and therefore 
what data had to be extracted to get the most accurate 
presentation of the prescriber’s department. Little varia-
tion in data output is expected for hospitals using Chip-

















































































Fig. 3 Appropriateness of antibiotics for UTI. Category A in accordance with the guideline-recommended first choice agents, marked in green; 
B in accordance with the guideline-recommended second choice agents, marked in yellow; C discordant with the guideline, marked in red; and 
other: antibiotics prescribed in less than 5% of cases, marked in grey
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EMR content. Hospitals using EPIC software, however, 
are able to personalize the EMR content to the needs of 
their facility. Thus, before the datasets of other hospitals 
can be used for comparison, specification of extracted 
data is necessary.
The feasibility study identified other points of consid-
eration as well. A large number of antibiotic prescrip-
tions were not evaluated for appropriateness. These were 
mainly the prescriptions that were excluded because 
they had other indications than RTI/UTI or because 
they were not considered as empiric therapy. To enable 
electronic evaluation of the quality of antibiotic use, we 
focused on empiric therapy because that is prescribed 
according to general guidelines. The data output did 
not include patient characteristics or diagnostic results, 
which precludes electronic evaluation of targeted ther-
apy. In addition, depending on the hospital, a number 
of prescriptions for RTI and UTI can be missed due to 
incorrectly selected indications by prescribers. Thus, one 
should keep in mind that this method enables to measure 
the appropriateness of a relatively large sample of antibi-
otic prescription for RTI/UTI and not the appropriate-
ness of all antibiotic prescriptions for that indication.
The rate of discrepancy between selected indication 
and documented indication in the EMR was comparable 
to the 74–90% accuracy rates reported by previous stud-
ies investigating the validity of automated indication reg-
istration [16–18, 23]. In Hospital B and C, mismatches 
were mainly caused by incorrectly selected cystitis where 
this should have been complicated UTI (n = 37 and 
n = 20 respectively). This also explains why cefuroxime 
and ceftriaxone were the most frequently prescribed 
agents for cystitis. This underscores that the accuracy 
rate needs to be considered when using the data for qual-
ity measurements and benchmarking. The difference 
between the accuracy rates of the hospitals might be par-
tially explained by the timing of data extraction: Hospital 
A implemented the automated tool in 2015, meaning the 
prescribers had three years to familiarize with the sys-
tem, while the data from Hospital B and C was extracted 
only a few months after implementation. Education and 
feedback to prescribers by local AST may be necessary to 
increase the accuracy of the data.
Mandatory prescription-indication documentation and 
the standardized data collection may considerably reduce 
the workload for local AST [12, 14, 25]. It makes manual 
data collection for a PPS probably superfluous, as it pre-
sents a framework for a more comprehensive approach. 
The mandatory selection of an indication might be seen 
as burdensome for prescribers. However, during the 
evaluation of our feasibility study prescribers informed 
us that they did not consider the intervention as such. 
They considered it not labour-intensive or considered 
it standard patient care. These responses are compa-
rable with what was previously reported by Beardsley 
and colleagues. In that study prescribers were surveyed 
on the burden of an automated prescription-indication 
tool. They judged it to be minor or occasionally burden-
some [23]. In the study of ten Oever and colleagues it 
was shown that the time needed to perform a PPS and 
report the measurements was 150 and 30 h, respectively 
[26]. As a result, quality measurements and improve-
ment activities are either performed on smaller scale, 
or not performed at all. Introducing mandatory indica-
tion registration also requires time and expertise. How-
ever, as opposed to PPS, the majority of time needs to 
be invested once, at the start of the project. Thereafter, 
time is needed to repeat the analysis (semi)annually or 
quarterly, which is less time consuming than perform-
ing a PPS and potentially generates much more data. In 
our study we already saw that with increasing experience 
the time needed for the implementation of the manda-
tory prescription format, data validation and analysis was 
significantly shorter in Hospital C. This leaves more time 
for the AST to focus on quality improvement activities. 
Analysis and benchmarking of the data can be performed 
by a regional or national party, which also assures inde-
pendent quality control. Ongoing surveillance of antibi-
otic use based on yearly results also enables evaluation 
of the antibiotic use for indications that occur less often, 
for instance HAP. These are often missed in a PPS or the 
results are not interpretable because of the small num-
bers. Finally, benchmarking on the national level facili-
tates comparison of the appropriateness of antimicrobial 
use between hospitals, providing additional targets for 
improvement [14, 27]. This was also demonstrated in 
our study. We  found that ACA was frequently inappro-
priately prescribed for both CAP as cystitis in all three 
hospitals. Also, in Hospital B and C, amoxicillin was 
prescribed in 33.3% of exacerbations COPD. These find-
ings suggest targets not only for local action, but also for 
national action.
Limitations
This study is subject to several limitations. First, the 
accuracy of the datasets relies on accurate indication 
selection by the prescribers. Human errors are inevitable, 
and the error rate might fluctuate over time. The accu-
racy of a random sample of the dataset should therefore 
be checked regularly, for example yearly. Second, some 
antibiotics might be prescribed based on pre-admis-
sion used antibiotics, previously cultured pathogens, or 
because of patient allergies. These prescriptions are cur-
rently unjustly labelled as being inappropriate. However, 
in previous studies it was shown that this does not influ-
ence the overall guideline adherence rate notable and 
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therefore can be ignored [28]. Another limitation is that 
the appropriateness of antimicrobial use was defined as 
being in accordance with the national guidelines, and not 
the local guidelines. Local guidelines are derived from the 
national guidelines and may contain adjustments accord-
ing to local resistance patterns [4]. However, this would 
mainly pose a difficulty for countries where a wide range 
of local resistance is observed, which can be solved by 
benchmarking per region instead of on the national level. 
In addition, we did not evaluate the appropriateness of 
treatment duration, which is also an important target to 
reduce antibiotic consumption [29]. This would require 
post-discharge antibiotic prescription data, which we 
could not retrieve from the datasets. And, we did not 
evaluate the accuracy of provider’s diagnosis, which is 
another important intervention for ASTs. The evalu-
ation tool in its current form focuses on whether the 
prescribed antibiotic is in accordance with the guideline 
for the presumed diagnosis. Finally, we compared three 
hospitals without considering comparability between 
these hospitals in terms of type, size and case-mix, which 
would be preferable for benchmarking on the national 
level.
Conclusion
We have demonstrated the real-life feasibility of man-
datory documenting the indication of all antibiot-
ics prescribed in EMR using ChipSoft  HIX or EPIC 
software for quality evaluation purposes. It enables a 
reliable and time-efficient method for systematic reg-
istration of the extent and appropriateness of empiric 
antimicrobial use. Initial local validation and, if neces-
sary, optimization of the datasets, however, is required 
to assure accuracy of the extracted data. The next step 
is now to implement this prescription-format in more 
hospitals in the Netherlands and internationally, for 
the purpose of national and international benchmark-
ing of the quality of in-hospital antibiotic use. To fur-
ther improve the quality of prescribing it would also 
be useful to embed local or national guidelines in the 
EMR, enabling direct feedback whenever an antibiotic 
is prescribed.
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